Lee Ainslie - Maverick Capital
Holding/activity history for Boston Scientific (BSX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q2 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2024 Q1 | 5,748 | 0.01 | Reduce 34.91% | 0.01 | $68.55 |
| 2023 Q4 | 8,831 | 0.01 | Buy | 0.01 | $57.86 |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.03 | |
| 2021 Q3 | 62,528 | 0.03 | Reduce 34.32% | 0.02 | $43.39 |
| 2021 Q2 | 95,196 | 0.04 | Add 187.38% | 0.03 | $42.76 |
| 2021 Q1 | 33,126 | 0.01 | Reduce 52.70% | 0.01 | $38.64 |
| 2020 Q4 | 70,041 | 0.04 | Add 8.94% | 0.00 | $35.95 |
| 2020 Q3 | 64,296 | 0.05 | Buy | 0.05 | $38.21 |
| 2019 Q1 | 0 | 0 | Sell 100.00% | 0.04 | |
| 2018 Q4 | 77,730 | 0.04 | Buy | 0.04 | $35.34 |
| 2018 Q2 | 0 | 0 | Sell 100.00% | 0.03 | |
| 2018 Q1 | 71,740 | 0.03 | Buy | 0.03 | $27.32 |